Changes in bone density and bone turnover in patients with rheumatoid arthritis treated with rituximab, a B cell depleting monoclonal antibody (HORUS TRIAL)

BMC Musculoskeletal Disorders

Meeting Abstract

Gillian Wheater¹  Kamran Naraghi²  Wan-Fai Ng³  Harish K Datta³  Mohsen Elshahaly⁴  Jacob M van Laar⁴  Stephen P Tuck⁴ 

[1] Department of Biochemistry, The James Cook University Hospital, Middlesbrough, UK;Department of Rheumatology, The James Cook University Hospital, Middlesbrough, UK;Musculoskeletal Research Group, Institute of Cellular Medicine, Newcastle University, Newcastle-upon-Tyne, UK;Musculoskeletal Research Group, Institute of Cellular Medicine, Newcastle University, Newcastle-upon-Tyne, UK;Department of Rheumatology, The James Cook University Hospital, Middlesbrough, UK;

关键词: Rheumatoid Arthritis;    Bone Mineral Density;    Osteoporosis;    Rheumatoid Arthritis Patient;    Bone Density;   

DOI  :  10.1186/1471-2474-14-S1-A10

来源: Springer

【 授权许可】

CC BY   
© Elshahaly et al; licensee BioMed Central Ltd. 2013